The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Hirota Fujiki sits on this spectrum.
This scientist: 302 publications — 79th percentile
79% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hirota Fujiki sits on this spectrum.
This scientist: 81 D-Index — 81st percentile
81% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Hirota Fujiki is affiliated with the National Cancer Research Institute in the United Kingdom. Their research spans several areas within biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular biology, oncology, surgery, and cancer research.
The scientist's work primarily addresses topics related to Helicobacter pylori-associated gastroenterology studies, cancer-related gene regulation, epigenetics and DNA methylation, cancer molecular pathways, and the interface between cancer, lipids, and metabolism.
Recent papers authored by Hirota Fujiki include the following:
Frequent co-authors collaborating with Hirota Fujiki include:
Publication venues where Hirota Fujiki's work has appeared include:
The focus of Hirota Fujiki's research encompasses detailed studies of molecular pathways involved in cancer and the role of specific proteins and tumor promoters in cancer progression. The work on Helicobacter pylori explores the bacterium's secreted proteins and their contribution to gastric cancer development, while other investigations address the impact of tumor promoters such as okadaic acid and endogenous inhibitors of protein phosphatase 2A (PP2A).
Overall, Hirota Fujiki's contributions lie at the intersection of microbiology, molecular cancer biology, and the biochemical mechanisms underlying tumor progression and prevention strategies.
Rie Nishiwaki-Matsushima;Tetsuya Ohta;Shinji Nishiwaki;Masami Suganuma
Masami Suganuma;Hirota Fujiki;Hiroko Suguri;Shigeru Yoshizawa
Shigeru Yoshizawa;Rie Matsushima;Mariyo F. Watanabe;Ken-ichi Harada
Masami Suganuma;Sachiko Okabe;Masumi Oniyama;Yukiko Tada
Masami Suganuma;Sachiko Okabe;Michael W. Marino;Ayako Sakai
Shigeru Yoshizawa;Takahiko Horiuchi;Hirota Fujiki;Takashi Yoshida
Masami Suganuma;Sachiko Okabe;Yasuko Kai;Naoko Sueoka
Hirota Fujiki;Masami Mori;Michie Nakayasu;Masaaki Terada
Masami Suganuma;Sachiko Okabe;Naoko Sueoka;Eisaburo Sueoka
Shun'ichiro Taniguchi;Hirota Fujiki;Hiroaki Kobayashi;Hiroki Go
Hirota Fujiki;Takashi Sugimura
B Friedman;A R Frackelton;A H Ross;J M Connors
Rie Matsushima;Shigeru Yoshizawa;Mariyo F. Watanabe;Ken-ichi Harada
Masahito Shimizu;Yasushi Fukutomi;Mitsuo Ninomiya;Kazuo Nagura
Naoko Sueoka;Masami Suganuma;Eisaburo Sueoka;Sachiko Okabe
Hirota Fujiki;Yasushi Tanaka;Ryohei Miyake;Ushio Kikkawa
Sachiko Okabe;Masami Suganuma;Moriaki Hayashi;Eisaburo Sueoka
Hirota Fujiki
Yoshihiro Fujita;Tetsuro Yamane;Masumi Tanaka;Katsuya Kuwata
Masami Suganuma;Hirota Fujiki;Hiroko Furuya-Suguri;Shigeru Yoshizawa
If you think any of the details on this page are incorrect, let us know.
University of Sharjah
Institut de Recherche de Chimie Paris
Animal and Plant Health Inspection Service
University of California, Davis
Oregon State University
National Institutes of Health
Centers for Disease Control and Prevention
MSD (United States)
University of Rostock
Genentech
Texas A&M University
Stanford University
Institut de Chimie des Substances Naturelles
Northwestern University
University of Maine
Sapienza University of Rome
